Results 81 to 90 of about 110,455,116 (191)
Colorectal cancer (CRC) is the third most common cancer in the world, with increasing morbidity and mortality. The current diagnosis and treatment plan rely on early detection and comprehensive treatment based on surgery.
Chengyang Chen, Xia Jiang, Zengren Zhao
doaj +1 more source
<p>PDF file - 315K, Immunostaining of ASS1, TS, and DHFR in representative urothelial carcinomas.</p>
Peter W. Szlosarek +32 more
openaire +1 more source
Targeting Argininosuccinate Synthetase in Cancer Therapy
There has been renewed interest in amino acid deprivation to treat various human cancers. Certain tumors do not express argininosuccinate synthetase (ASS) and therefore are unable to synthesize arginine from citrulline.
Dinh, Vy +6 more
core +1 more source
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Joséphine Carpentier,1 Iuliia Pavlyk,1 Uma Mukherjee,2 Peter E Hall,2 Peter W Szlosarek1,2 1Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK; 2Department of Medical Oncology ...
Carpentier J +4 more
doaj
Finding My Path: Listening, Learning, and Leading in Rare Disease: The 2025 Hower Award
Annals of the Child Neurology Society, EarlyView.
Andrea Gropman
wiley +1 more source
This comprehensive review summarizes gastric cancer epidemiology, multifactorial risk factors (like infectious, dietary, genetic), pathogenesis such as precancerous evolution, molecular alterations, and a focus on the bidirectional interactions between gastric cancer cells and macrophages in the tumor microenvironment.
Yixuan Xin +6 more
wiley +1 more source
The nucleotide (nt) sequences of the genes encoding argininosuccinate synthetase synthetase from Escheria coli K-12 (argG) and Saccharomyces cerevisiae (ARG1) were determined.
Stalon, Victor +8 more
core +1 more source
Arginine deprivation therapy for malignant melanoma
Jung-Ki Yoon,1,2 Arthur E Frankel,3 Lynn G Feun,4 Suhendan Ekmekcioglu,1 Kevin B Kim11Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Hwasung Public Health Center, Hwasung, South ...
Yoon JK +4 more
doaj
Argininosuccinate synthetase 1 (ASS1) expression and arginine availability are key metabolic determinants that influence tumor fitness and regulate immune interactions within the tumor microenvironment (TME).
Hila Tishler +28 more
doaj +1 more source

